Miyatake Mayumi, Narita Minoru, Shibasaki Masahiro, Nakamura Atsushi, Suzuki Tsutomu
Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawaku, Tokyo 142-8501, Japan.
Eur J Neurosci. 2005 Sep;22(6):1476-88. doi: 10.1111/j.1460-9568.2005.04325.x.
Methamphetamine (METH) is a strongly addictive psychostimulant that dramatically affects the central nervous system (CNS). On the other hand, protein kinase C (PKC) plays a major role in cellular regulatory and signalling processes that involve protein phosphorylation. The purpose of this study was to investigate the role of neuronal and astrocytic PKC in changes in the central glutamatergic system induced by METH. We show here that in vitro treatment with METH caused the phosphorylation of both neuronal and astrocytic PKC and the activation of astrocytes in cortical neuron/glia co-cultures. Treatment of cortical neuron/glia co-cultures with either the PKC activator phorbol 12,13-dibutyrate (PDBu) or glutamate also caused the PKC-dependent activation of astrocytes. The PKC inhibitor chelerythrine suppressed the Ca2+ responses to glutamate in both cortical neurons and astrocytes. Moreover, a low concentration of PDBu significantly enhanced the Ca2+ responses to glutamate, but not to dopamine, in both cortical neurons and astrocytes. Notably, treatment with METH also enhanced the Ca2+ responses to glutamate in cortical neurons. The activation of astrocytes induced by METH was also reversed by co-treatment with glutamate receptor antagonists (ifenprodil, DNQX or MPEP) in cortical neuron/glia co-cultures. In the conditioned place preference paradigm, intracerebroventricular administration of glutamate receptor antagonists (ifenprodil, DNQX or MPEP) attenuated the METH-induced rewarding effect. These findings provide evidence that the changes in PKC-dependent neuronal and astrocytic glutamatergic transmission induced by METH may, at least in part, contribute to the development of psychological dependence on METH.
甲基苯丙胺(METH)是一种极易成瘾的精神兴奋剂,会对中枢神经系统(CNS)产生显著影响。另一方面,蛋白激酶C(PKC)在涉及蛋白质磷酸化的细胞调节和信号传导过程中起主要作用。本研究的目的是探讨神经元和星形胶质细胞PKC在METH诱导的中枢谷氨酸能系统变化中的作用。我们在此表明,在皮质神经元/神经胶质细胞共培养物中,用METH进行体外处理会导致神经元和星形胶质细胞PKC的磷酸化以及星形胶质细胞的激活。用PKC激活剂佛波酯12,13 - 二丁酸酯(PDBu)或谷氨酸处理皮质神经元/神经胶质细胞共培养物也会导致PKC依赖的星形胶质细胞激活。PKC抑制剂白屈菜红碱抑制了皮质神经元和星形胶质细胞对谷氨酸的Ca2 +反应。此外,低浓度的PDBu显著增强了皮质神经元和星形胶质细胞对谷氨酸而非多巴胺的Ca2 +反应。值得注意的是,用METH处理也增强了皮质神经元对谷氨酸的Ca2 +反应。在皮质神经元/神经胶质细胞共培养物中,用谷氨酸受体拮抗剂(ifenprodil、DNQX或MPEP)共同处理也可逆转METH诱导的星形胶质细胞激活。在条件性位置偏爱范式中,脑室内注射谷氨酸受体拮抗剂(ifenprodil、DNQX或MPEP)可减弱METH诱导的奖赏效应。这些发现提供了证据,表明METH诱导的PKC依赖的神经元和星形胶质细胞谷氨酸能传递变化可能至少部分促成了对METH的心理依赖的发展。